FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485 | -44.3% | 1,725,000 | 0.0% | 0.19% | -23.2% |
| Q2 2023 | $8,056 | +8.2% | 1,725,000 | -12.7% | 0.25% | -43.4% |
| Q1 2023 | $7,446 | +215.1% | 1,975,000 | +163.3% | 0.44% | +234.8% |
| Q4 2022 | $2,363 | -99.9% | 750,000 | 0.0% | 0.13% | +37.5% |
| Q3 2022 | $2,258,000 | +20.9% | 750,000 | 0.0% | 0.10% | -4.0% |
| Q2 2022 | $1,868,000 | -67.9% | 750,000 | 0.0% | 0.10% | -59.0% |
| Q1 2022 | $5,828,000 | +86.3% | 750,000 | 0.0% | 0.24% | +187.1% |
| Q4 2021 | $3,128,000 | -47.3% | 750,000 | 0.0% | 0.08% | -36.1% |
| Q3 2021 | $5,940,000 | -2.0% | 750,000 | 0.0% | 0.13% | +8.1% |
| Q2 2021 | $6,060,000 | +4.8% | 750,000 | +39.1% | 0.12% | +20.6% |
| Q1 2021 | $5,781,000 | – | 539,264 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |